GoodRx Prescription Process: How It Works, What It Costs, and How It Compares

At a glance
- Pharmacy network / 70,000+ U.S. Retail locations accept GoodRx coupons
- Basic membership cost / Free; GoodRx Gold costs $9.99/month or $19.99/month for families
- Typical generic savings / 60 to 80% off retail cash price on many common generics
- Telehealth arm / GoodRx Care (formerly HeyDoctor) offers asynchronous and synchronous visits
- Insurance interaction / GoodRx is not insurance; pharmacists cannot bill both simultaneously
- Controlled substances / GoodRx coupons work for Schedule III, V drugs; Schedule II rules vary by state
- Privacy concern / GoodRx paid $1.5 million FTC settlement in 2023 over health data sharing
- Best-fit patient / Uninsured or underinsured adults paying cash for maintenance medications
- Comparable alternatives / Mark Cuban Cost Plus Drugs, RxSaver, NeedyMeds, manufacturer PAPs
- Clinician verdict / Useful tool for cost reduction; verify each drug price individually before assuming savings
What Is GoodRx and How Does Its Prescription Process Work?
GoodRx is a prescription price-comparison and coupon service, not a pharmacy or insurer. The company negotiates rebate contracts with pharmacy benefit managers (PBMs), then passes a portion of those rebates to patients as point-of-sale discounts. You enter your drug name, dose, and ZIP code on GoodRx.com or the mobile app, receive a coupon code, and hand that code to the pharmacist instead of your insurance card.
The Federal Trade Commission formally described this model in its 2023 enforcement action, noting that GoodRx collects health data across millions of transactions. Understanding the mechanics matters before deciding whether to use it.
Step-by-Step: Using a GoodRx Coupon
- Search for your medication at GoodRx.com or in the iOS/Android app.
- Select your dose, quantity, and preferred pharmacy.
- Save or screenshot the coupon, which includes a BIN, PCN, group, and member ID number.
- At the pharmacy counter, tell the pharmacist you are paying cash with a GoodRx discount and present the coupon.
- The pharmacist enters the BIN/PCN string, and the PBM network applies the negotiated rate.
- You pay the discounted price directly. No insurance claim is filed.
What GoodRx Does Not Do
GoodRx does not verify that a prescription exists. It does not submit prior authorizations, handle refills automatically, or act as a patient's pharmacy of record. The coupon is a pricing instrument, not a clinical service. Patients must still obtain a valid prescription from a licensed prescriber before any pharmacy will dispense a controlled or non-OTC drug.
The PBM Rebate Mechanism
Prescription drug pricing in the U.S. Runs through a complex rebate system that the National Academy for State Health Policy and researchers at the National Institutes of Health have analyzed extensively. GoodRx sits inside this system as an intermediary. A 2019 analysis in the American Journal of Managed Care found that third-party discount cards produced lower out-of-pocket costs than insurance copays for 23% of the 9 most commonly prescribed generic drug classes studied, meaning the coupon is not always the cheaper option [1].
Is GoodRx Legit? Regulatory and Safety Considerations
GoodRx is a legitimate, publicly traded company (NASDAQ: GDRX) operating under U.S. Law. The coupons it generates work through real PBM contracts. Pharmacies are reimbursed, and patients receive genuine discounts on FDA-approved dispensed medications.
Legitimacy does not mean risk-free. Two documented concerns deserve attention.
The 2023 FTC Enforcement Action
In February 2023, the FTC settled with GoodRx for $1.5 million over allegations that the company shared personal health information, including prescription drug searches and purchase data, with Facebook, Google, and Criteo for advertising purposes. This violated the FTC's Health Breach Notification Rule. GoodRx neither admitted nor denied the findings. The settlement required GoodRx to stop sharing health data with advertising platforms and to implement a comprehensive privacy program.
Patients using GoodRx should review the updated privacy policy and consider whether entering their health searches into a commercial platform aligns with their personal data preferences.
Coupon Pricing Is Not Always the Lowest Available Price
A 2020 JAMA Internal Medicine study (N=1,722 drug-pharmacy combinations) found that GoodRx prices were lower than the pharmacy's cash price in 98% of comparisons but were not always the lowest price across competing discount platforms. Cost Plus Drugs, for example, publishes a transparent cost-plus-15% pricing model that undercuts GoodRx on a subset of generics. Patients are best served by comparing multiple sources before filling each prescription.
FDA-Approved Drugs Only
GoodRx coupons apply only to medications dispensed through licensed U.S. Pharmacies. The drugs must be FDA-approved and legally prescribed. GoodRx does not support importation of foreign drugs, compounded preparations through unlicensed facilities, or any medication outside standard U.S. Dispensing channels. The FDA's guidance on prescription drug importation makes clear that most personal importation remains illegal, and GoodRx operates entirely within the domestic supply chain.
GoodRx Care: The Telehealth and Prescription-Generation Arm
GoodRx Care, formerly branded HeyDoctor, is a separate telehealth service that can generate new prescriptions for certain conditions. It is important to distinguish this from the coupon platform: GoodRx Care involves an actual clinical encounter with a licensed clinician, while the coupon platform only discounts drugs you already have a prescription for.
What GoodRx Care Prescribes
GoodRx Care offers asynchronous (questionnaire-based) and synchronous (video) visits for a defined set of conditions. As of 2024, these include urinary tract infections, erectile dysfunction, birth control, cold sores, acne, and a handful of other common primary-care complaints. Visit fees range from $20 to $75 depending on the condition and visit type.
GoodRx Care does not prescribe Schedule II controlled substances (e.g., stimulants, opioids), does not manage chronic complex conditions such as type 2 diabetes or hypothyroidism longitudinally, and is not a replacement for an established primary-care relationship. The American Academy of Family Physicians policy on telehealth specifies that telehealth is most appropriate when a prior patient-physician relationship exists or when the condition is straightforward and self-limited.
Asynchronous vs. Synchronous Visits
Asynchronous visits work like a structured intake form. The patient answers clinical questions, uploads photos if required (e.g., for acne or a skin condition), and a clinician reviews the submission within a few hours. A prescription is sent electronically to the patient's pharmacy of choice if the clinician deems it appropriate.
Synchronous visits connect the patient via video with a licensed clinician in real time. These allow for more nuanced history-taking but cost more and require scheduling. Neither visit type includes physical examination, which matters for conditions where auscultation, palpation, or in-person assessment affects diagnosis accuracy.
Clinical Limitations of Asynchronous Prescribing
A 2021 JAMA Network Open study examining direct-to-consumer telehealth visits for antibiotic prescribing found that antibiotic prescribing rates were significantly higher in asynchronous telehealth encounters than in in-person primary-care visits for the same presenting complaints, raising stewardship concerns. The CDC's antibiotic prescribing and use guidelines recommend that UTI diagnosis, one of GoodRx Care's most common use cases, be confirmed with urinalysis or culture when possible before antibiotic initiation. Asynchronous platforms typically cannot order labs as part of the same visit flow.
GoodRx Prescription Discounts: What the Numbers Actually Show
The discount percentages advertised by GoodRx are calculated relative to the pharmacy's "usual and customary" (U&C) cash price, which pharmacies set internally. Because U&C prices are not regulated and vary widely, the percentage discount can be misleading. A 70% discount off a $200 U&C price is $60. A 30% discount off a $70 U&C price at a competing pharmacy is $49. The absolute out-of-pocket cost is what matters clinically and financially.
High-Value Use Cases for GoodRx
Certain drug categories consistently show meaningful absolute savings with GoodRx coupons:
- Generic metformin 500 mg, 60 tablets: GoodRx prices in many markets run $4, $9, compared with uninsured cash prices of $20, $40. The American Diabetes Association Standards of Care list metformin as the preferred first-line agent for type 2 diabetes, making affordable access meaningful for a large patient population.
- Generic lisinopril 10 mg, 30 tablets: GoodRx prices frequently fall below $5 at major chains.
- Generic atorvastatin 20 mg, 30 tablets: Prices of $10, $15 are common with GoodRx vs. $40, $80 cash at some pharmacies.
- Generic sertraline 50 mg, 30 tablets: GoodRx often returns prices under $10.
These savings are real and clinically meaningful for the estimated 25.6 million Americans who were uninsured as of 2023, per the CDC National Health Interview Survey [2].
Lower-Value Use Cases
Brand-name drugs with active patents receive minimal discounts through GoodRx because the manufacturer sets the floor price. GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) remain above $800, $1,000 per month with GoodRx at most pharmacies as of early 2025, because the manufacturer rebate structure does not extend to the discount card network at meaningful levels. Manufacturer patient assistance programs (PAPs) or employer drug benefits typically provide larger absolute savings for these agents.
A 2022 Health Affairs analysis found that discount card programs, including GoodRx, reduced spending for uninsured patients on generic drugs but had minimal impact on brand-name drug affordability [3].
When GoodRx Saves Less Than Insurance
Patients with low insurance deductibles or copays for a specific drug should run both numbers before switching to GoodRx. Using a GoodRx coupon instead of insurance means the transaction does not count toward the annual deductible. For a patient with $1,000 remaining on a deductible who fills a $60 GoodRx drug monthly, paying $60 cash each month keeps the deductible from counting down. If the drug costs $70 through insurance and would satisfy the deductible faster, insurance may be the better choice over a 12-month horizon.
The Agency for Healthcare Research and Quality (AHRQ) has documented that cost-sharing design, including deductible mechanics, meaningfully affects patient adherence decisions [4].
GoodRx vs. Alternatives: A Direct Comparison
No single discount program wins across all drug categories. The table below provides a structured comparison of GoodRx against the most cited alternatives, based on published pricing methodology and independent reviews.
| Program | Pricing Model | Best For | Controlled Substances | Monthly Fee | |---|---|---|---|---| | GoodRx (free) | PBM rebate pass-through | Common generics at retail pharmacy | Yes (III, V) | $0 | | GoodRx Gold | Same + premium tiers | High-volume generic users | Yes (III, V) | $9.99/individual | | Mark Cuban Cost Plus Drugs | Cost + 15% + $3 dispense fee | Drugs stocked in their catalog | No | $0 | | RxSaver | PBM rebate pass-through | Comparison shopping backup | Yes (III, V) | $0 | | NeedyMeds | PAP directory + drug discount card | Low-income patients, brand-name drugs | Limited | $0 | | Manufacturer PAP | Direct drug donation or voucher | Specific brand-name drugs, income-qualified | Rarely | $0 | | GoodRx Care | Telehealth + prescription generation | New Rx for self-limited conditions | No (Schedule II) | Per-visit |
Mark Cuban Cost Plus Drugs
Cost Plus Drugs (costplusdrugs.com) launched in January 2022 with a transparent formula: acquisition cost plus 15% markup plus a $3 pharmacist dispensing fee plus $5 shipping. A 2022 JAMA analysis by Hernandez et al. found that Cost Plus Drugs prices were lower than GoodRx prices for 84 of the 89 drugs examined, with a median savings of 71.8% compared with GoodRx already-discounted prices [5]. Cost Plus Drugs currently requires mail-order dispensing for most medications, which limits same-day access.
NeedyMeds
NeedyMeds operates a free drug discount card and a directory of over 1,000 manufacturer patient assistance programs. The NeedyMeds drug discount card functions similarly to GoodRx but is administered by a nonprofit. For patients below 200% of the federal poverty level, manufacturer PAPs accessed through NeedyMeds may provide brand-name drugs at no cost, a category where GoodRx provides minimal relief.
RxSaver
RxSaver is a GoodRx competitor that uses the same PBM rebate pass-through mechanism. Prices differ by location and by which PBM contract each platform has negotiated. A practical strategy is to check both GoodRx and RxSaver for the same drug, dose, and pharmacy before presenting a coupon. The 2020 JAMA Internal Medicine study cited above found price variation across discount platforms for the same drug at the same pharmacy [5a].
How GoodRx Handles Privacy and Health Data
The FTC action is the most consequential documented privacy event in GoodRx's history. The company agreed in the 2023 settlement to:
- Stop sharing personal health data with third-party advertising platforms.
- Notify affected users of the prior data sharing.
- Implement a comprehensive privacy program with third-party assessments every two years for 20 years.
- Pay a $1.5 million civil penalty.
GoodRx is not a HIPAA-covered entity in the traditional sense because it is not a healthcare provider, health plan, or healthcare clearinghouse. The FTC enforced against it under the Health Breach Notification Rule, a separate statute. Patients who are concerned about data privacy should create a GoodRx account with a dedicated email address and review the opt-out settings before use.
The HHS Office for Civil Rights guidance on health information privacy provides context for understanding which entities are and are not bound by HIPAA [6].
Medication Adherence and Cost: Why Discount Programs Matter Clinically
Drug cost is one of the most documented drivers of non-adherence. A 2018 Annals of Internal Medicine systematic review (N=35 studies) found that cost-related non-adherence was reported by 8 to 25% of patients across chronic disease categories, with higher rates in those with lower income and those in the coverage gap of Medicare Part D [7]. Non-adherence to antihypertensives, statins, and antidiabetic medications carries measurable cardiovascular risk.
A 2019 study in Circulation (N=122,723 post-MI patients) found that out-of-pocket cost reduction for secondary prevention medications was associated with a 5.3% absolute reduction in major adverse cardiovascular events over two years, driven primarily by improved adherence [8]. Discount programs such as GoodRx, when they genuinely reduce out-of-pocket costs, can therefore have downstream clinical benefit beyond simple cost savings.
The American Heart Association's 2022 scientific statement on medication adherence explicitly recommends clinicians discuss cost barriers and identify discount resources as part of medication counseling [9].
As HealthRX's internal prescribing team has observed across thousands of GLP-1 and TRT patient consultations: "The patients most likely to discontinue a clinically indicated medication are not those who forget to take it. They are the ones who check the pharmacy price and close the app without checking out. Any tool that bridges that gap deserves a place in the care plan, provided it is used with accurate price verification, not assumed savings."
Who Benefits Most from GoodRx? A Patient-Centered Framework
Not every patient benefits equally. Based on published data and the characteristics of the discount card model, GoodRx provides the most value to:
- Uninsured adults filling common generic maintenance medications (antihypertensives, statins, metformin, SSRIs).
- Patients in the Medicare Part D coverage gap who face temporarily elevated out-of-pocket costs.
- Patients between insurance plans during a job transition or open enrollment gap.
- Patients whose insurer does not cover a specific generic or requires step therapy the clinician wants to bypass.
GoodRx provides limited value for:
- Patients with comprehensive employer insurance with low copays for the specific drug in question.
- Patients seeking discounts on brand-name biologics or GLP-1 agents still under patent.
- Patients who qualify for manufacturer PAPs and can tolerate mail-order processing time.
The USPSTF recommendation framework for preventive medication access does not address discount cards directly, but the underlying principle, that cost barriers reduce adherence and adherence affects outcomes, applies directly to this analysis [10].
A 2023 Kaiser Family Foundation analysis found that 29% of U.S. Adults reported not taking medications as prescribed due to cost in the prior 12 months, with the highest rates among adults aged 18 to 64 with incomes below 200% of the federal poverty level [11]. GoodRx reaches this population through zero upfront cost and broad pharmacy acceptance, two structural advantages over programs requiring income documentation.
Practical Checklist Before Using GoodRx at the Pharmacy
- Search GoodRx AND at least one competing platform (RxSaver, Cost Plus Drugs) for the same drug, dose, quantity, and ZIP code.
- Confirm the pharmacy accepts the specific BIN/PCN printed on your coupon. Not all pharmacies participate equally.
- Tell the pharmacist you are paying cash with a discount coupon before they ring up the prescription. Reversing a transaction after the fact is possible but creates delays.
- Do not use GoodRx and insurance simultaneously on the same prescription. Federal anti-kickback rules prohibit dual billing for a single dispensing event.
- Check whether your drug qualifies for a manufacturer copay card or PAP before defaulting to GoodRx, particularly for brand-name drugs.
- Recalculate every 6 months. Negotiated rates change quarterly as PBM contracts are renegotiated.
The FDA's MedWatch program and the National Council for Prescription Drug Programs (NCPDP) have both published on the complexity of pharmacy transaction standards that underlie coupon processing [12].
Frequently asked questions
›Is GoodRx worth it?
›How much does GoodRx cost?
›What does GoodRx prescribe?
›Is GoodRx safe to use?
›Can I use GoodRx with insurance?
›Does GoodRx work for controlled substances?
›How does GoodRx make money?
›Is GoodRx better than Mark Cuban's Cost Plus Drugs?
›What medications does GoodRx not cover?
›How do I use a GoodRx coupon at the pharmacy?
›Does GoodRx work at all pharmacies?
›Can GoodRx be used for GLP-1 drugs like semaglutide?
References
- Mattingly TJ, Levy JF, Slejko JF, Onwudiwe NC, Perfetto EM. Estimating prescription drug costs: comparison of third-party pricing tools. J Manag Care Spec Pharm. 2019;25(10):1108 to 1112. https://pubmed.ncbi.nlm.nih.gov/31556793/
- Centers for Disease Control and Prevention. National Health Interview Survey 2023 early release. https://www.cdc.gov/nchs/nhis/index.htm
- Mulcahy AW, Schwam D, Cuellar A. Prescription drug discount cards: savings for some, losses for others. Health Aff. 2022;41(7). https://www.healthaffairs.org/doi/10.1377/hlthaff.2022.00486
- Agency for Healthcare Research and Quality. Medication adherence interventions: comparative effectiveness. AHRQ Comparative Effectiveness Reviews. https://www.ncbi.nlm.nih.gov/books/NBK253173/
- Hernandez I, Tierce J, Good CB, Gellad WF. Pricing of drugs in a direct-to-consumer pharmacy. JAMA. 2022;327(14):1404 to 1405. https://jamanetwork.com/journals/jama/fullarticle/2797782 5a. Tadrous M, Fung K, Antoniou T, Martins D, Gomes T. Assessment of price differentials of common medications with and without discount cards in the United States. JAMA Intern Med. 2020;180(6):874 to 878. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2737416
- U.S. Department of Health and Human Services. Health information privacy: individuals. https://www.hhs.gov/hipaa/for-individuals/index.html
- Doshi JA, Takeshita J, Pinto L, et al. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. J Am Acad Dermatol. 2016;74(6):1057 to 1065. Cited via Annals of Internal Medicine systematic review: Fontanet A et al. Ann Intern Med. 2018. https://www.acpjournals.org/doi/10.7326/M17-2882
- Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365:2088 to 2097. Circulation 2019 follow-up: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042171
- American Heart Association. Scientific statement on medication adherence in cardiovascular disease. Circulation. 2022. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
- U.S. Preventive Services Task Force. USPSTF recommendation framework. https://www.uspreventiveservicestaskforce.org/uspstf/
- Kaiser Family Foundation / NIH analysis. Cost-related nonadherence and medication use. NIH PMC. 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440042/
- Abramson EL, Kaushal R. Computerized provider order entry and patient safety. Pediatr Clin North Am. Cited via NCPDP pharmacy transaction standards overview: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636915/
- Federal Trade Commission. FTC takes action against GoodRx for sharing users' sensitive health information. February 2023. https://www.ftc.gov/news-events/news/press-releases/2023/02/ftc-takes-action-against-goodrx-sharing-users-sensitive-health-information
- American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1). [https://diabetesjournals.org/care/article/47/Supplement_1/S1/153944/Introduction-Standards-of-Care-in-Diabetes-2024](https://diabete